CytoSorbents Corporation (CTSO)

[laker5]

It's true that reverse stock splits usually result in a decrease in the price of the stock post-split. But it doesn't have to be this way.

Besides the 600 million shares outstanding, the stock price may have suffered recently from a mass exodus of shareholders from CTSO to Aethlon Medical (AEMD), a company with a device broadly similar to Cytosorbents' but used to treat different conditions and with a different technology.

AEMD's device, called the hemopurifier, was named last week to TIME magazine's BEST INVENTIONS of 2014.

Cytosorbents' product is having good commercial success so far in Europe and India and may be a good buy around .17 or so.